Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Mahipal

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Oncotargets and Therapy|November 1, 2021
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of InfigratinibJames Yu, Amit Mahipal, Richard Kim
Cancers|July 30, 2020
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving ParadigmSakti Chakrabarti, Mandana Kamgar, Amit Mahipal
Cancer Control : Journal of the Moffitt Cancer Center|December 21, 2013
Epidermal growth factor receptor inhibitors: coming of ageAmit Mahipal, Nishi Kothari, Shilpa Gupta
Cancers|June 10, 2022
Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and OpportunitiesSakti Chakrabarti, Mandana Kamgar, Amit Mahipal
Journal of the National Comprehensive Cancer Network : JNCCN|October 21, 2015
Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?Amit Mahipal, Minsig Choi, Richard Kim
Cancers|March 6, 2021
Research Progress of Biliary Tract CancersLionel Aurelien A Kankeu Fonkoua, Amit Mahipal
Expert Review of Anticancer Therapy|November 21, 2022
Pemigatinib in cholangiocarcinoma with a FGFR2 rearrangement or fusionMichael H Storandt, Zhaohui Jin, Amit Mahipal
Expert Opinion on Investigational Drugs|March 8, 2021
Targeting FGFR in intrahepatic cholangiocarcinoma [iCCA]: leading the way for precision medicine in biliary tract cancer [BTC]?Gabriella Aitcheson, Amit Mahipal, Binu V John
Chinese Clinical Oncology|May 22, 2020
Systemic therapy for advanced hepatocellular carcinoma: targeted therapiesSri Harsha Tella, Anuhya Kommalapati, Amit Mahipal
Oncotargets and Therapy|May 22, 2024
Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to DateMichael H Storandt, Zhaohui Jin, Amit Mahipal
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Oncotargets and Therapy|November 1, 2021
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of InfigratinibJames Yu, Amit Mahipal, Richard Kim
Cancers|July 30, 2020
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving ParadigmSakti Chakrabarti, Mandana Kamgar, Amit Mahipal
Cancer Control : Journal of the Moffitt Cancer Center|December 21, 2013
Epidermal growth factor receptor inhibitors: coming of ageAmit Mahipal, Nishi Kothari, Shilpa Gupta
Cancers|June 10, 2022
Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and OpportunitiesSakti Chakrabarti, Mandana Kamgar, Amit Mahipal
Journal of the National Comprehensive Cancer Network : JNCCN|October 21, 2015
Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?Amit Mahipal, Minsig Choi, Richard Kim
Cancers|March 6, 2021
Research Progress of Biliary Tract CancersLionel Aurelien A Kankeu Fonkoua, Amit Mahipal
Expert Review of Anticancer Therapy|November 21, 2022
Pemigatinib in cholangiocarcinoma with a FGFR2 rearrangement or fusionMichael H Storandt, Zhaohui Jin, Amit Mahipal
Expert Opinion on Investigational Drugs|March 8, 2021
Targeting FGFR in intrahepatic cholangiocarcinoma [iCCA]: leading the way for precision medicine in biliary tract cancer [BTC]?Gabriella Aitcheson, Amit Mahipal, Binu V John
Chinese Clinical Oncology|May 22, 2020
Systemic therapy for advanced hepatocellular carcinoma: targeted therapiesSri Harsha Tella, Anuhya Kommalapati, Amit Mahipal
Oncotargets and Therapy|May 22, 2024
Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to DateMichael H Storandt, Zhaohui Jin, Amit Mahipal
Pageof 18